Timothy John Garnett serves as Executive at MapLight Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Timothy John Garnett has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Oct 27, 2025 involved receiving (via award) 6,294 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Oct 27, 2025 | MPLT | $0 | Award | 6,294 | $N/A | Discretionary |
Timothy John Garnett currently holds 6,294 shares of MapLight Therapeutics, Inc. (MPLT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Timothy John Garnett has been a net neutral trader of MPLT stock. They have purchased $0 and sold $0 worth of shares.
Timothy John Garnett's most recent insider trade was on Oct 27, 2025, when they sold 6,294 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted